Assuntos
Biópsia/métodos , Colonografia Tomográfica Computadorizada/métodos , Endoscopia do Sistema Digestório/métodos , Obstrução Intestinal , Linfoma de Zona Marginal Tipo Células B , Linfoma Folicular , Idoso , Colo Sigmoide/patologia , Diagnóstico Diferencial , Humanos , Íleo/patologia , Obstrução Intestinal/diagnóstico , Obstrução Intestinal/etiologia , Linfoma de Zona Marginal Tipo Células B/complicações , Linfoma de Zona Marginal Tipo Células B/diagnóstico por imagem , Linfoma de Zona Marginal Tipo Células B/patologia , Linfoma Folicular/complicações , Linfoma Folicular/diagnóstico por imagem , Linfoma Folicular/patologia , Masculino , Estadiamento de Neoplasias , Tomografia por Emissão de Pósitrons/métodos , Intensificação de Imagem Radiográfica/métodosAssuntos
Duodeno/irrigação sanguínea , Neoplasias Gastrointestinais/complicações , Neoplasias Gastrointestinais/terapia , Nevo Azul/complicações , Nevo Azul/terapia , Polidocanol/administração & dosagem , Soluções Esclerosantes/administração & dosagem , Escleroterapia/métodos , Neoplasias Cutâneas/complicações , Neoplasias Cutâneas/terapia , Malformações Vasculares/etiologia , Malformações Vasculares/terapia , Anemia/etiologia , Anemia/terapia , Criança , Duodeno/diagnóstico por imagem , Endoscopia Gastrointestinal , Feminino , Hemorragia Gastrointestinal/diagnóstico por imagem , Hemorragia Gastrointestinal/etiologia , Hemorragia Gastrointestinal/terapia , Neoplasias Gastrointestinais/diagnóstico por imagem , Humanos , Injeções Intralesionais , Nevo Azul/diagnóstico por imagem , Neoplasias Cutâneas/diagnóstico por imagem , Resultado do Tratamento , Malformações Vasculares/diagnóstico por imagemAssuntos
Colo/irrigação sanguínea , Colo/patologia , Veias Mesentéricas/patologia , Idoso , Colectomia/métodos , Colo/diagnóstico por imagem , Colo/cirurgia , Colonoscopia , Diagnóstico Diferencial , Humanos , Hiperplasia/diagnóstico por imagem , Hiperplasia/patologia , Hiperplasia/cirurgia , MasculinoAssuntos
Endoscopia do Sistema Digestório/métodos , Mucosa Gástrica/diagnóstico por imagem , Gastrite/diagnóstico por imagem , Granuloma/diagnóstico por imagem , Imagem de Banda Estreita/métodos , Gastropatias/diagnóstico por imagem , Amoxicilina/administração & dosagem , Antibacterianos/administração & dosagem , Claritromicina/administração & dosagem , Diagnóstico Diferencial , Quimioterapia Combinada , Feminino , Mucosa Gástrica/patologia , Gastrite/tratamento farmacológico , Gastrite/microbiologia , Gastrite/patologia , Granuloma/patologia , Infecções por Helicobacter , Helicobacter pylori , Humanos , Pessoa de Meia-Idade , Rabeprazol/administração & dosagem , Gastropatias/patologiaAssuntos
Adenocarcinoma/cirurgia , Colite Ulcerativa/complicações , Ressecção Endoscópica de Mucosa/métodos , Neoplasias Retais/cirurgia , Adenocarcinoma/etiologia , Adenocarcinoma/patologia , Idoso , Dissecação/métodos , Endoscopia Gastrointestinal/métodos , Feminino , Humanos , Neoplasias Retais/etiologia , Neoplasias Retais/patologiaRESUMO
AIM: Sessile serrated adenomas/polyps (SSA/Ps) have been proposed as precursors of colorectal cancer. The aims of this investigation were to compare the endoscopic findings of SSA/Ps with those of other serrated lesions and to compare the histological findings of SSA/Ps with those of conventional adenomas. METHOD: We retrospectively reviewed colonoscopy records at our institution from 1984 to 2013 and identified cases of endoscopically or surgically resected conventional adenomas and serrated lesions, including SSA/Ps, hyperplastic polyps (HPs) and traditional serrated adenomas (TSAs). The colonoscopic findings of SSA/Ps were compared with those of the other two serrated lesions and histological findings were compared among all groups of lesions. RESULTS: There were 79 HPs in 68 patients, 77 SSA/Ps in 63 patients, 167 TSAs in 145 patients and 6324 conventional adenomas in 4129 patients. The inverted type and flat-elevated type were more frequent among SSA/Ps than among the other two types of serrated lesions. Magnifying colonoscopy revealed that a round and open pit pattern, expanded crypt openings and varicose microvascular vessels were more frequently observed among SSA/Ps than among the other types. The incidence of high-grade dysplasia or carcinoma among SSA/Ps (13.0%) was significantly higher than that among HPs (0%, P < 0.001) and equivalent to that among conventional adenomas (12.3%). CONCLUSION: SSA/Ps have colonoscopic features distinct from those of HPs and TSAs. The malignant potential of SSA/Ps seems to be equal to that of conventional adenomas.
Assuntos
Adenocarcinoma/patologia , Adenoma/patologia , Pólipos do Colo/patologia , Colonoscopia , Neoplasias Colorretais/patologia , Microvasos/patologia , Adenocarcinoma/irrigação sanguínea , Adenocarcinoma/complicações , Adenoma/irrigação sanguínea , Adenoma/complicações , Idoso , Colo/patologia , Neoplasias Colorretais/irrigação sanguínea , Neoplasias Colorretais/complicações , Feminino , Humanos , Hiperplasia , Masculino , Pessoa de Meia-Idade , Estudos RetrospectivosRESUMO
Isolated or nonsyndromic tooth agenesis or hypodontia is the most common human malformation. It has been associated with mutations in MSX1, PAX9, EDA, AXIN2, EDAR, EDARADD, and WNT10A. GREMLIN 2 (GREM2) is a strong bone morphogenetic protein (BMP) antagonist that is known to regulate BMPs in embryogenesis and tissue development. Bmp4 has been shown to have a role in tooth development. Grem2(-/-) mice have small, malformed maxillary and mandibular incisors, indicating that Grem2 has important roles in normal tooth development. Here, we demonstrate for the first time that GREM2 mutations are associated with human malformations, which include isolated tooth agenesis, microdontia, short tooth roots, taurodontism, sparse and slow-growing hair, and dry and itchy skin. We sequenced WNT10A, WNT10B, MSX1, EDA, EDAR, EDARADD, AXIN2, and PAX9 in all 7 patients to rule out the effects of other ectodermal dysplasias and other tooth-related genes and did not find mutations in any of them. GREM2 mutations exhibit variable expressivity even within the same families. The inheritance is autosomal dominant with incomplete penetrance. The expression of Grem2 during the early development of mouse teeth and hair follicles and the evaluation of the likely effects of the mutations on the protein structure substantiate these new findings.
Assuntos
Peptídeos e Proteínas de Sinalização Intercelular/fisiologia , Mutação de Sentido Incorreto/genética , Anormalidades Dentárias/genética , Sequência de Aminoácidos , Animais , Anodontia/genética , Citocinas , Humanos , Hibridização In Situ , Peptídeos e Proteínas de Sinalização Intercelular/genética , Camundongos , Dados de Sequência Molecular , Mutação/genética , Dente/crescimento & desenvolvimentoAssuntos
Colite Colagenosa/complicações , Colite Colagenosa/diagnóstico , Endoscopia Gastrointestinal , Gastroenterite/complicações , Gastroenterite/diagnóstico , Enteropatias Perdedoras de Proteínas/complicações , Enteropatias Perdedoras de Proteínas/diagnóstico , Idoso de 80 Anos ou mais , Colite Colagenosa/patologia , Feminino , Gastroenterite/patologia , Humanos , Enteropatias Perdedoras de Proteínas/patologia , Índice de Gravidade de DoençaRESUMO
Nuclear factor kappa B (NF-κB) signaling plays critical roles in many physiological and pathological processes, including regulating organogenesis. Down-regulation of NF-κB signaling during development results in hypohidrotic ectodermal dysplasia. The roles of NF-κB signaling in tooth development, however, are not fully understood. We examined mice overexpressing IKKß, an essential component of the NF-κB pathway, under keratin 5 promoter (K5-Ikkß). K5-Ikkß mice showed supernumerary incisors whose formation was accompanied by up-regulation of canonical Wnt signaling. Apoptosis that is normally observed in wild-type incisor epithelium was reduced in K5-Ikkß mice. The supernumerary incisors in K5-Ikkß mice were found to phenocopy extra incisors in mice with mutations of Wnt inhibitor, Wise. Excess NF-κB activity thus induces an ectopic odontogenesis program that is usually suppressed under physiological conditions.
Assuntos
Incisivo/embriologia , NF-kappa B/fisiologia , Odontogênese/fisiologia , Germe de Dente/embriologia , Proteínas Adaptadoras de Transdução de Sinal , Ameloblastos/citologia , Amelogenina/análise , Animais , Apoptose/fisiologia , Proteínas Morfogenéticas Ósseas/genética , Esmalte Dentário/citologia , Epitélio/embriologia , Proteínas Hedgehog/fisiologia , Quinase I-kappa B/fisiologia , Imageamento Tridimensional/métodos , Incisivo/anormalidades , Queratina-15/genética , Camundongos , Camundongos Mutantes , Microrradiografia/métodos , Mutação/genética , Receptores Patched , Fenótipo , Regiões Promotoras Genéticas/genética , Receptores de Superfície Celular/fisiologia , Germe de Dente/anormalidades , Dente Supranumerário/etiologia , Dente Supranumerário/genética , Via de Sinalização Wnt/genética , Via de Sinalização Wnt/fisiologia , Microtomografia por Raio-X/métodosRESUMO
BACKGROUND: Brain metastases (BM) are a common in patients with lung cancer. Although whole-brain radiation therapy (WBRT) is the standard therapy, it may have a risk of decline in cognitive function of patients. In this study, we evaluated the efficacy of gefitinib alone without radiation therapy for the treatment of patients with BM from lung adenocarcinoma. MATERIALS AND METHODS: Eligible patients had BM from lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations. Gefitinib was given at 250 mg orally once a day until tumor progression or unacceptable toxicity. RESULTS: Forty-one patients were enrolled. The response rate was 87.8%. No patient experienced grade ≥4 toxicity. The median progression-free survival time was 14.5 months (95% CI, 10.2-18.3 months), and the median overall survival time was 21.9 months (95% CI, 18.5-30.3 months). In compared with L858R, exon 19 deletion was associated with better outcome of patients after treatment with gefitinib in both progression-free (p = 0.003) and overall survival (p = 0.025). CONCLUSION: Favorable response of BM to gefitinib even without irradiation was demonstrated. Exon 19 deletion was both a predictive and prognostic marker of patients with BM treated by gefitinib.
Assuntos
Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/patologia , Antineoplásicos/uso terapêutico , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/secundário , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/patologia , Inibidores de Proteínas Quinases/uso terapêutico , Quinazolinas/uso terapêutico , Adenocarcinoma/genética , Adenocarcinoma/mortalidade , Adenocarcinoma de Pulmão , Adulto , Idoso , Antineoplásicos/administração & dosagem , Antineoplásicos/efeitos adversos , Povo Asiático , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/mortalidade , Receptores ErbB/antagonistas & inibidores , Receptores ErbB/genética , Éxons , Feminino , Gefitinibe , Humanos , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/mortalidade , Masculino , Pessoa de Meia-Idade , Mutação , Inibidores de Proteínas Quinases/administração & dosagem , Inibidores de Proteínas Quinases/efeitos adversos , Quinazolinas/administração & dosagem , Quinazolinas/efeitos adversos , Fatores de Risco , Resultado do TratamentoRESUMO
BACKGROUND AND PURPOSE: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with no effective treatment. Fasudil hydrochloride (fasudil), a potent rho kinase (ROCK) inhibitor, is useful for the treatment of ischaemic diseases. In previous reports, fasudil improved pathology in mouse models of Alzheimer's disease and spinal muscular atrophy, but there is no evidence in that it can affect ALS. We therefore investigated its effects on experimental models of ALS. EXPERIMENTAL APPROACH: In mice motor neuron (NSC34) cells, the neuroprotective effect of hydroxyfasudil (M3), an active metabolite of fasudil, and its mechanism were evaluated. Moreover, the effects of fasudil, 30 and 100 mg·kg(-1), administered via drinking water to mutant superoxide dismutase 1 (SOD1(G93A)) mice were tested by measuring motor performance, survival time and histological changes, and its mechanism investigated. KEY RESULTS: M3 prevented motor neuron cell death induced by SOD1(G93A). Furthermore, M3 suppressed both the increase in ROCK activity and phosphorylated phosphatase and tensin homologue deleted on chromosome 10 (PTEN), and the reduction in phosphorylated Akt induced by SOD1(G93A). These effects of M3 were attenuated by treatment with a PI3K inhibitor (LY294002). Moreover, fasudil slowed disease progression, increased survival time and reduced motor neuron loss, in SOD1(G93A) mice. Fasudil also attenuated the increase in ROCK activity and PTEN, and the reduction in Akt in SOD1(G93A) mice. CONCLUSIONS AND IMPLICATIONS: These findings indicate that fasudil may be effective at suppressing motor neuron degeneration and symptom progression in ALS. Hence, fasudil may have potential as a therapeutic agent for ALS treatment.
Assuntos
1-(5-Isoquinolinasulfonil)-2-Metilpiperazina/análogos & derivados , Esclerose Lateral Amiotrófica/tratamento farmacológico , Neurônios Motores/efeitos dos fármacos , Inibidores de Proteínas Quinases/farmacologia , 1-(5-Isoquinolinasulfonil)-2-Metilpiperazina/administração & dosagem , 1-(5-Isoquinolinasulfonil)-2-Metilpiperazina/farmacologia , Esclerose Lateral Amiotrófica/fisiopatologia , Animais , Modelos Animais de Doenças , Progressão da Doença , Relação Dose-Resposta a Droga , Masculino , Camundongos Transgênicos , Neurônios Motores/patologia , Fármacos Neuroprotetores/farmacologia , Fosfatidilinositol 3-Quinases/metabolismo , Fosforilação/efeitos dos fármacos , Inibidores de Proteínas Quinases/administração & dosagem , Proteínas Proto-Oncogênicas c-akt/metabolismo , Superóxido Dismutase/genética , Superóxido Dismutase-1 , Taxa de Sobrevida , Quinases Associadas a rho/antagonistas & inibidoresRESUMO
The oral mucosa plays critical roles in protection, sensation, and secretion and can be classified into masticatory, lining, and specialized mucosa that are known to be functionally, histologically, and clinically distinct. Each type of oral mucosa is believed to develop through discrete molecular mechanisms, which remain unclear. MicroRNAs (miRNAs) are 19 to 25nt non-coding small single-stranded RNAs that negatively regulate gene expression by binding target mRNAs. miRNAs are crucial for fine-tuning of molecular mechanisms. To investigate the role of miRNAs in oral mucosa development, we examined mice with mesenchymal (Wnt1Cre;Dicer(fl/fl)) conditional deletion of Dicer. Wnt1Cre;Dicer(fl/fl) mice showed trans-differentiation of lining mucosa into an epithelium with masticatory mucosa/ skin-specific characteristics. Up-regulation of Fgf signaling was found in mutant lining mucosal epithelium that was accompanied by an increase in Fgf7 expression in mutant mesenchyme. Mesenchyme miRNAs thus have an indirect effect on lining mucosal epithelial cell growth/differentiation.
Assuntos
RNA Helicases DEAD-box/fisiologia , Fator 7 de Crescimento de Fibroblastos/biossíntese , Regulação da Expressão Gênica no Desenvolvimento , Mesoderma/metabolismo , MicroRNAs/fisiologia , Mucosa Bucal/crescimento & desenvolvimento , Ribonuclease III/fisiologia , Animais , Transdiferenciação Celular/genética , RNA Helicases DEAD-box/genética , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Fator 7 de Crescimento de Fibroblastos/genética , Deleção de Genes , Mesoderma/citologia , Camundongos , Camundongos Transgênicos , MicroRNAs/genética , Mucosa Bucal/citologia , Mucosa Bucal/metabolismo , Crista Neural/citologia , Ribonuclease III/genética , Transdução de Sinais/genética , Proteína Wnt1/genética , Proteína Wnt1/fisiologiaRESUMO
Viral vector-mediated gene transfer has become increasingly valuable for primate brain research, in particular for application of genetic methods (e.g. optogenetics) to study neuronal circuit functions. Neuronal cell tropisms and infection patterns are viable options for obtaining viral vector-mediated transgene delivery that is selective for particular neuronal pathways. For example, several types of viral vectors can infect axon terminals (retrograde infections), which enables targeted transgene delivery to neurons that directly project to a particular viral injection region. Although recent studies in rodents have demonstrated that adeno-associated virus serotype 8 (AAV8) and 9 (AAV9) efficiently transduce neurons, the tropisms and infection patterns remain poorly understood in primate brains. Here, we constructed recombinant AAV8 or AAV9, which expressed an enhanced green fluorescent protein (EGFP) gene driven by a ubiquitous promoter (AAV8-EGFP and AAV9-EGFP, respectively), and stereotaxically injected it into several brain regions in marmosets and macaque monkeys. Immunohistochemical analyses revealed almost exclusive colocalization of EGFP fluorescence via AAV9-mediated gene transfer with a neuron-specific marker, indicating endogenous neuronal tropism of AAV9, which was consistent with our previous results utilizing AAV8. Injections of either AAV8-EGFP or AAV9-EGFP into the marmoset striatum resulted in EGFP expression in local striatal neurons as a result of local infection, as well as expression in dopaminergic neurons of the substantia nigra via retrograde transport along nigrostriatal axonal projections. Retrograde infections were also observed in the frontal cortex and thalamus, which are known to have direct projections to the striatum. These local and retrograde gene transfers were further demonstrated in the geniculocortical pathway of the marmoset visual system. These findings indicate promising capabilities of AAV8 and AAV9 to deliver molecular tools into a range of primate neural systems in pathway-specific manners through their neuronal tropisms and infection patterns.
Assuntos
Mapeamento Encefálico , Encéfalo/fisiologia , Dependovirus/fisiologia , Vias Neurais/fisiologia , Neurônios/metabolismo , Animais , Encéfalo/metabolismo , Callithrix , Dependovirus/classificação , Dependovirus/genética , Técnicas de Transferência de Genes , Vetores Genéticos/fisiologia , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Masculino , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismoRESUMO
The overexpression of reduced expression in immortalized cells (REIC)/Dickkopf-3 (Dkk-3), a tumor suppressor gene, induced apoptosis in human prostatic and testicular cancer cells. The aim of this study is to examine the potential of REIC/Dkk-3 as a therapeutic target against breast cancer. First, the in vitro apoptotic effect of Ad-REIC treatment was investigated in breast cancer cell lines and the adenovirus-mediated overexpression of REIC/Dkk-3 was thus found to lead to apoptotic cell death in a c-Jun-NH(2)-kinase (JNK) phosphorylaion-dependent manner. Moreover, an in vivo apoptotic effect and MCF/Wt tumor growth inhibition were observed in the mouse model after intratumoral Ad-REIC injection. As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-REIC treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to doxorubicin and of the P-glycoprotein expression. Ad-REIC treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through JNK activation, and sensitized its drug resistance against doxorubicin. Therefore, not only apoptosis induction but also the reversal of anticancer drug resistance was achieved using Ad-REIC. We suggest that REIC/Dkk-3 is a novel target for breast cancer treatment and that Ad-REIC might be an attractive agent against drug-resistant cancer in combination with conventional antineoplastic agents.
Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP/biossíntese , Adenoviridae , Antibióticos Antineoplásicos/farmacologia , Apoptose , Neoplasias da Mama/terapia , Regulação para Baixo , Doxorrubicina/farmacologia , Resistência a Múltiplos Medicamentos , Resistencia a Medicamentos Antineoplásicos , Terapia Genética , Peptídeos e Proteínas de Sinalização Intercelular/biossíntese , Membro 1 da Subfamília B de Cassetes de Ligação de ATP/genética , Proteínas Adaptadoras de Transdução de Sinal , Animais , Antibióticos Antineoplásicos/uso terapêutico , Apoptose/efeitos dos fármacos , Apoptose/genética , Neoplasias da Mama/genética , Neoplasias da Mama/metabolismo , Quimiocinas , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/genética , Doxorrubicina/uso terapêutico , Resistência a Múltiplos Medicamentos/efeitos dos fármacos , Resistência a Múltiplos Medicamentos/genética , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Resistencia a Medicamentos Antineoplásicos/genética , Ativação Enzimática/efeitos dos fármacos , Ativação Enzimática/genética , Feminino , Células HeLa , Humanos , Peptídeos e Proteínas de Sinalização Intercelular/genética , MAP Quinase Quinase 4/genética , MAP Quinase Quinase 4/metabolismo , Camundongos , Camundongos Nus , Transplante de NeoplasiasRESUMO
BACKGROUND AND OBJECTIVE: Our previous study showed that topical alendronate, an inhibitor of bone resorption, reduces root resorption and ankylosis for 21 d after replantation of rat teeth. The aim of the present study was to evaluate the long-term inhibitory effects of topical alendronate in the replanted teeth. MATERIAL AND METHODS: The rat maxillary first molars were extracted, placed in saline containing 1 mm alendronate (alendronate group) or saline (saline group) for 5 min and then replanted. The maxillae were dissected at 60 and 120 d. Microcomputed tomography horizontal sections at three root levels were analyzed for root and bone resorption, ankylosis and pulp mineralization. RESULTS: In the alendronate group at 60 and 120 d, the frequencies of resorption of roots and bone were lower than those in the saline group. The p values show statistical significances of lower frequencies in the alendronate group than in the saline group by chi-square test (see Table 1). Ankylosis and pulp mineralization occurred in the alendronate and saline groups. Bone marrow spaces were narrowed in conjunction with bone tissue expansion around the replanted teeth in the alendronate group. CONCLUSION: The inhibitory effects of topical alendronate were retained on root and bone resorption, but not on ankylosis and pulp mineralization, in the replanted teeth for 4 mo. Alendronate might also stimulate bone formation around the rat replanted teeth.
Assuntos
Alendronato/uso terapêutico , Perda do Osso Alveolar/prevenção & controle , Conservadores da Densidade Óssea/uso terapêutico , Reabsorção da Raiz/prevenção & controle , Reimplante Dentário/efeitos adversos , Animais , Calcificações da Polpa Dentária/etiologia , Masculino , Ratos , Ratos Wistar , Reabsorção da Raiz/etiologia , Tomografia Computadorizada por Raios X , Anquilose Dental/etiologiaRESUMO
Tunisian olive oils have been traditionally used as a medicinal food for chronic inflammation. To investigate the antiallergic effect of virgin olive oil samples from five principal olive varieties grown in various regions of Tunisia, we used the type I allergy reaction model using rat basophilic leukemia (RBL-2H3) cells and different dilutions of olive oil samples to determine beta-hexosaminidase release inhibition at two different response stages. Results showed that the Sayali olive oil significantly inhibited beta-hexosaminidase release by the IgE antibody-sensitized, BSA antigen-stimulated RBL-2H3 cells at the antibody-antigen binding stage. The result of our experiment shows that the anti-allergic effect of olive oil at this binding stage may be dependent on their flavone content. The Zarrazi olive oil significantly inhibited beta-hexosaminidase release at the antigen-receptor binding stage. Moreover, we investigated the effect of olive oil samples on histamine release and production of cytokines by activated human basophilic (KU812) cells. Different dilutions of Sayali olive oil dose-dependently inhibited the production of tumor necrosis factor-alpha (TNF-alpha) and interleukin-4 (IL-4), and different dilutions of Zarrazi olive oil dose-dependently inhibited histamine release and IL-4 production by calcium ionophore A23187 plus phorbol 12-myristate 13-acetate (PMA)-stimulated KU812 cells.
Assuntos
Leucemia Basofílica Aguda/metabolismo , Óleos de Plantas/farmacologia , Fator de Necrose Tumoral alfa/biossíntese , Animais , Reações Antígeno-Anticorpo , Linhagem Celular Tumoral , Técnica de Fratura por Congelamento , Liberação de Histamina , Mediadores da Inflamação/metabolismo , Interleucina-4/metabolismo , Leucemia Basofílica Aguda/enzimologia , Leucemia Basofílica Aguda/patologia , Microscopia Eletrônica , Azeite de Oliva , beta-N-Acetil-Hexosaminidases/metabolismoRESUMO
BACKGROUND: Matrilysin (MMP-7), a member of the matrix metalloproteinase (MMP) family of proteins, is expressed in various types of malignant tumours. There have been no previous studies of the correlation between matrilysin expression and melanoma. OBJECTIVES: Protein expression of matrilysin was evaluated in human cutaneous melanomas, metastatic melanomas, acquired common melanocytic naevi and Spitz naevi, and the data were corrected with the clinicopathological factors. METHODS: We retrospectively investigated 18 primary melanomas, 15 metastatic melanomas, 10 common melanocytic naevi and five Spitz naevi samples at our clinic using immunohistochemistry (IHC). Both promatrilysin and active matrilysin were found in the melanoma tissue extracts by Western immunoblotting. In situ hybridization demonstrated that melanoma cells selectively express matrilysin mRNA. RESULTS: Of the melanoma samples, 29 of 33 (87 x 9%) were positive for matrilysin, including 14 of 18 (77 x 8%) primary cutaneous melanomas and 15 of 15 (100%) metastatic melanomas. In contrast, matrilysin was not expressed in common naevi or Spitz naevi. The matrilysin IHC staining score in primary melanomas was associated with the presence of metastases, tumour thickness and TNM staging (P=0 x 001, 0 x 025 and 0 x 021, respectively). The 5-year overall survival was 26.3% for matrilysin-positive cases and 100% for matrilysin-negative cases among melanoma specimen. CONCLUSIONS: We found matrilysin expression in primary melanomas and in metastatic melanomas. We further demonstrated that the matrilysin IHC staining score was associated with invasive depth of primary melanoma lesions and metastases. Our observations indicate that matrilysin may be associated with melanoma progression, and may enhance melanoma tumour cell invasion. Therefore, matrilysin may be potentially valuable as a prognostic indicator to predict the clinical behaviour of melanoma.